SCHEMBL17827484

SCHEMBL17827484

[2H]c1cc2cccnc2n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.40
PARP1 P09874 1/20 0.40
MTNR1A P48039 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 3/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MMP2 P08253 1/20 0.37
MAPT P10636 1/20 0.37
MMP9 P14780 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
MMP8 P22894 1/20 0.37
CCR1 P32246 1/20 0.37
THPO P40225 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL256379 0.79 PARP1 (0.50) DYRK1APARP1MTNR1AL3MBTL1KDM4E
SCHEMBL29845529 0.79 PARP1 (0.50) DYRK1APARP1MTNR1AL3MBTL1KDM4E
Bromide SCHEMBL28427695 0.78 PARP1 (0.49) DYRK1APARP1MTNR1AL3MBTL1KDM4E
SCHEMBL29468208 0.71 AHR (0.47) DYRK1AMTNR1AKDM4ECYP3A4CYP2D6
SCHEMBL29865575 0.67 PARP1 (0.55) PARP1MTNR1AL3MBTL1KDM4ECYP3A4
SCHEMBL28822882 0.67 PARP1 (0.55) PARP1MTNR1AL3MBTL1KDM4ECYP3A4
SCHEMBL29712289 0.67 BRD4 (0.50) PARP1MTNR1AL3MBTL1KDM4ECYP3A4
SCHEMBL2614748 0.67 BRD4 (0.50) PARP1MTNR1AL3MBTL1KDM4ECYP3A4
SCHEMBL17818443 0.66 CYP2C19 (0.73) L3MBTL1LMNAMAPTTSHRHTT
SCHEMBL5437233 0.66 AXL (0.64) DYRK1APARP1MTNR1AL3MBTL1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160168147-A1 ISOTOPICALLY ENRICHED AZAINDOLES VERTEX PHARMA (US) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168147-A1 ISOTOPICALLY ENRICHED AZAINDOLES JAK2, JAK1, JAK3 DYRK1A 373/4885PARP1 1336/4885MTNR1A 2804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.